I'm LongbridgeAI, I can summarize articles.Gainers
- Karyopharm Therapeutics (NASDAQ:KPTI) stock moved upwards by 10.0% to $0.04 during Monday's after-market session. The company's market cap stands at $1.2 million.
- Fractyl Health (NASDAQ:GUTS) stock moved upwards by 5.89% to $0.95. The company's market cap stands at $12.3 million.
- Ovid Therapeutics (NASDAQ:OVID) stock moved upwards by 5.26% to $3.0. The company's market cap stands at $556.5 million.
- ARS Pharmaceuticals (NASDAQ:SPRY) stock increased by 3.17% to $3.25. The market value of their outstanding shares is at $280.4 million. As per the press release, Q3 earnings came out 2 days ago.
- Altimmune (NASDAQ:ALT) shares moved upwards by 2.99% to $2.18. The company's market cap stands at $404.5 million.
- CEL-SCI (AMEX:CVM) shares rose 2.96% to $1.39. The company's market cap stands at $25.5 million.
Losers
- Tvardi Therapeutics (NASDAQ:TVRD) shares declined by 8.5% to $1.29 during Monday's after-market session. The company's market cap stands at $12.7 million.
- Acadia Pharmaceuticals (NASDAQ:ACAD) shares decreased by 7.28% to $15.3. The market value of their outstanding shares is at $3.6 billion. The company's, Q3 earnings came out 3 days ago.
- Estrella Immunopharma (NASDAQ:ESLA) stock fell 5.24% to $0.49. The company's market cap stands at $16.3 million.
- Obsidian Therapeutics (NASDAQ:OBX) shares decreased by 5.18% to $13.0. The market value of their outstanding shares is at $856.4 million.
- ALX Oncology Holdings (NASDAQ:ALXO) stock fell 5.06% to $1.22. The market value of their outstanding shares is at $155.4 million.
- Optimi Health (NASDAQ:OPTH) stock decreased by 4.63% to $2.38. The market value of their outstanding shares is at $13.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock1,057characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.
